Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.

Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanko, A., Heinonen, E., Scheinin, T. M., Tolppanen, E. M., Vihko, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1984
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976974/
https://www.ncbi.nlm.nih.gov/pubmed/6498064
_version_ 1782135164672933888
author Alanko, A.
Heinonen, E.
Scheinin, T. M.
Tolppanen, E. M.
Vihko, R.
author_facet Alanko, A.
Heinonen, E.
Scheinin, T. M.
Tolppanen, E. M.
Vihko, R.
author_sort Alanko, A.
collection PubMed
description Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only 1.9% received postoperative endocrine treatment and 6.5% chemotherapy. No significant relationship between the presence or concentrations of oestrogen or progesterone receptor and the disease-free interval was observed. It is therefore possible that the positive relationship between these variables reported in some investigations reflects an influence by adjuvant endocrine measures.
format Text
id pubmed-1976974
institution National Center for Biotechnology Information
language English
publishDate 1984
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19769742009-09-10 Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Alanko, A. Heinonen, E. Scheinin, T. M. Tolppanen, E. M. Vihko, R. Br J Cancer Research Article Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only 1.9% received postoperative endocrine treatment and 6.5% chemotherapy. No significant relationship between the presence or concentrations of oestrogen or progesterone receptor and the disease-free interval was observed. It is therefore possible that the positive relationship between these variables reported in some investigations reflects an influence by adjuvant endocrine measures. Nature Publishing Group 1984-11 /pmc/articles/PMC1976974/ /pubmed/6498064 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Alanko, A.
Heinonen, E.
Scheinin, T. M.
Tolppanen, E. M.
Vihko, R.
Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title_full Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title_fullStr Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title_full_unstemmed Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title_short Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
title_sort oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976974/
https://www.ncbi.nlm.nih.gov/pubmed/6498064
work_keys_str_mv AT alankoa oestrogenandprogesteronereceptorsanddiseasefreeintervalinprimarybreastcancer
AT heinonene oestrogenandprogesteronereceptorsanddiseasefreeintervalinprimarybreastcancer
AT scheinintm oestrogenandprogesteronereceptorsanddiseasefreeintervalinprimarybreastcancer
AT tolppanenem oestrogenandprogesteronereceptorsanddiseasefreeintervalinprimarybreastcancer
AT vihkor oestrogenandprogesteronereceptorsanddiseasefreeintervalinprimarybreastcancer

Ejemplares similares